131 related articles for article (PubMed ID: 16777671)
1. Lipids and the pathogenesis of Alzheimer's disease: is there a link?
Mielke MM; Lyketsos CG
Int Rev Psychiatry; 2006 Apr; 18(2):173-86. PubMed ID: 16777671
[TBL] [Abstract][Full Text] [Related]
2. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.
Ingelsson M; Jesneck J; Irizarry MC; Hyman BT; Rebeck GW
Neurosci Lett; 2004 Sep; 367(2):228-31. PubMed ID: 15331159
[TBL] [Abstract][Full Text] [Related]
3. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
[TBL] [Abstract][Full Text] [Related]
5. Cyp46 polymorphisms in Alzheimer's disease: a review.
Garcia AN; Muniz MT; Souza e Silva HR; da Silva HA; Athayde-Junior L
J Mol Neurosci; 2009 Nov; 39(3):342-5. PubMed ID: 19705089
[TBL] [Abstract][Full Text] [Related]
6. Genetic association of CYP46 and risk for Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Dement Geriatr Cogn Disord; 2004; 18(3-4):257-60. PubMed ID: 15286456
[TBL] [Abstract][Full Text] [Related]
7. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
Borroni B; Archetti S; Agosti C; Akkawi N; Brambilla C; Caimi L; Caltagirone C; Di Luca M; Padovani A
Neurobiol Aging; 2004 Jul; 25(6):747-51. PubMed ID: 15165699
[TBL] [Abstract][Full Text] [Related]
8. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
Montine TJ; Markesbery WR; Zackert W; Sanchez SC; Roberts LJ; Morrow JD
Am J Pathol; 1999 Sep; 155(3):863-8. PubMed ID: 10487843
[TBL] [Abstract][Full Text] [Related]
9. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
[TBL] [Abstract][Full Text] [Related]
10. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.
Kabbara A; Payet N; Cottel D; Frigard B; Amouyel P; Lambert JC
Neurosci Lett; 2004 Jun; 363(2):139-43. PubMed ID: 15172102
[TBL] [Abstract][Full Text] [Related]
11. Cholesterol and pathological processes in Alzheimer's disease.
Yanagisawa K
J Neurosci Res; 2002 Nov; 70(3):361-6. PubMed ID: 12391598
[TBL] [Abstract][Full Text] [Related]
12. What can lipidomics tell us about the pathogenesis of Alzheimer disease?
Xiang Y; Lam SM; Shui G
Biol Chem; 2015 Dec; 396(12):1281-91. PubMed ID: 26351920
[TBL] [Abstract][Full Text] [Related]
13. Greasing the wheels of Abeta clearance in Alzheimer's disease: the role of lipids and apolipoprotein E.
Fan J; Donkin J; Wellington C
Biofactors; 2009; 35(3):239-48. PubMed ID: 19472365
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. Lipids and Alzheimer's disease.
Garner B
Biochim Biophys Acta; 2010 Aug; 1801(8):747-9. PubMed ID: 20547302
[No Abstract] [Full Text] [Related]
16. Molecular genetics of Alzheimer's disease and aging.
Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population.
Ma SL; Tang NL; Lam LC; Chiu HF
Int Psychogeriatr; 2006 Mar; 18(1):37-45. PubMed ID: 16734927
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol 25-hydroxylase on chromosome 10q is a susceptibility gene for sporadic Alzheimer's disease.
Papassotiropoulos A; Lambert JC; Wavrant-De Vrièze F; Wollmer MA; von der Kammer H; Streffer JR; Maddalena A; Huynh KD; Wolleb S; Lutjohann D; Schneider B; Thal DR; Grimaldi LM; Tsolaki M; Kapaki E; Ravid R; Konietzko U; Hegi T; Pasch T; Jung H; Braak H; Amouyel P; Rogaev EI; Hardy J; Hock C; Nitsch RM
Neurodegener Dis; 2005; 2(5):233-41. PubMed ID: 16909003
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.
Kölsch H; Lütjohann D; Ludwig M; Schulte A; Ptok U; Jessen F; von Bergmann K; Rao ML; Maier W; Heun R
Mol Psychiatry; 2002; 7(8):899-902. PubMed ID: 12232784
[TBL] [Abstract][Full Text] [Related]
20. A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology.
Blain JF; Aumont N; Théroux L; Dea D; Poirier J
Eur J Neurosci; 2006 Sep; 24(5):1245-51. PubMed ID: 16965549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
